Physician profile
Mackenzie E Gaw
NPI 1023741402
$438.75
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $93.34 · 2023: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $62.86 | 2022-2023 | |
| Alkermes, INC. | $46.84 | 2023 | Aristada, Lybalvi |
| Abbvie INC. | $46.62 | 2023 | |
| Dexcom, INC. | $31.17 | 2022-2023 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $30.89 | 2023 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $29.07 | 2023 | |
| Idorsia Pharmaceuticals US INC | $26.87 | 2022-2023 | Quviviq |
| Corium, LLC | $22.57 | 2023 | Azstarys |
| Organon LLC | $20.22 | 2023 | Nexplanon |
| Takeda Pharmaceuticals U.S.A., INC. | $19.48 | 2023 | Trintellix |
| Ironshore Pharmaceuticals INC. | $17.71 | 2022 | |
| Axsome Therapeutics, INC. | $16.58 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.08 | 2022 | |
| Exact Sciences Corporation | $13.70 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $13.20 | 2023 | Trelegy Ellipta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.18 | 2023 | |
| Astellas Pharma US INC | $12.71 | 2023 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzie Gaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.